PMV Pharmaceuticals Revenue and Competitors

Cranbury Township,

Location

$236M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • PMV Pharmaceuticals's estimated annual revenue is currently $9.6M per year.(i)
  • PMV Pharmaceuticals's estimated revenue per employee is $155,000
  • PMV Pharmaceuticals's total funding is $236M.
  • PMV Pharmaceuticals's current valuation is $798.7M. (January 2022)

Employee Data

  • PMV Pharmaceuticals has 62 Employees.(i)
  • PMV Pharmaceuticals grew their employee count by 24% last year.

PMV Pharmaceuticals's People

NameTitleEmail/Phone
1
Co-Founder, President & CEOReveal Email/Phone
2
COO and CFOReveal Email/Phone
3
COO & CFOReveal Email/Phone
4
SVP, Drug Discovery and CMCReveal Email/Phone
5
VP, Information TechnologyReveal Email/Phone
6
SVP, Head Corporate Development & Investor RelationsReveal Email/Phone
7
General Counsel & Head OperationsReveal Email/Phone
8
SVP, Head Clinical Development & Medical AffairsReveal Email/Phone
9
VP, Drug Safety and PharmacovigilanceReveal Email/Phone
10
VP, BiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is PMV Pharmaceuticals?

PMV Pharma is developing first-in-class p53 regulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.

keywords:N/A

$236M

Total Funding

62

Number of Employees

$9.6M

Revenue (est)

24%

Employee Growth %

$798.7M

Valuation

N/A

Accelerator

PMV Pharmaceuticals News

2022-03-22 - PMV Pharmaceuticals to Participate in the 42nd Annual ...

CRANBURY, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the...

2022-03-22 - PMV Pharmaceuticals Reports Fourth Quarter and Full Year ...

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53.

2020-08-03 - PMV Pharma nabs $70M for tumor suppressor programs

PMV Pharmaceuticals is topping up its coffers—just eight months after raising $62 million in its series C round, the cancer biotech is reeling in another $70 million. The capital will advance a suite of candidates targeting p53, a tumor-suppressing protein that is mutated in many cancers. Spons ...

2020-08-03 - PMV Pharma Closes $70 Million in Series D Financing

CRANBURY, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations, announced the completion of a $70 million Series D financing round. Avoro Capita ...

2017-02-22 - PMV Pharma gets $74M boost for personalized chemistry

It wields a variety of anticancer mechanisms, including DNA repair and programmed cell death. That makes it a very attractive field of research — but it hasn’t yet delivered in the clinic. PMV Pharma plans to change that with a chemistry-centric approach to binding and correcting the function o ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12M83-5%N/A